Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NicVAX phase I/II trial begins enrollment

Feb. 21, 2003

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Jan. 29, 2003

Xenova buys out ImmuLogic's interests in TA-CD and TA-NIC programs

Jan. 17, 2003

AME-359 protects rats from cocaine overdose

Jan. 14, 2003

CeNeS outlicenses CEE-03-310 to Swiss biopharmaceutical company

Jan. 3, 2003

Reduced liver iron content in thalassemic patients treated with ICL-670

Dec. 13, 2002

Microbially produced kappa opioid receptor antagonist identified by Japanese research group

Nov. 18, 2002

Commit lozenge approved by the FDA for over-the-counter sale

Nov. 14, 2002

Tropane analogue RTI-336 as a potential therapeutic for cocaine abuse

Nov. 12, 2002

SSR-591813: a selective partial nicotinic alpha4beta receptor agonist for nicotine addiction

Nov. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...